Company

ARJUNA Therapeutics

Pharmaceutical Manufacturing Milladoiro, A Coruña, Es 10 employees

Employees: 10
Contacts: 4
Emails: 4
Phones: 2

ARJUNA Therapeutics Overview

Headquarters: Milladoiro, A Coruña, Es
Industry: Pharmaceutical Manufacturing
Employees: 10
Founded: 2019
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

About ARJUNA Therapeutics

We are developing an entirely novel class of orally available small molecules to address untreatable cancers. Our first drug, Ag5, aims to redefine the treatment landscape for solid tumours on both sides of the blood brain barrier by targeting the 30% of all cancers that generate high levels of Reactive Oxygen Species. This large group contains cancers driven by mutations in the KRAS gene, triple negative breast cancer and glioblastoma-all of which are urgent unmet medical needs with large potential markets. We have a deep pipeline of follow on medicines. Our goal is to revolutionise cancer treatment for patients and their doctors.

ARJUNA Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

ARJUNA Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Martin Treder	Chief Scientific Officer	Heidelberg, Baden-württemberg, Germany	Email Phone
Konstantina Georgieva	VP Operations at Arjuna Therapeutics	Bulgaria	Email
Charlie Sheppard		San Francisco Bay Area, United States	Email
Nacho De Marco	CEO at Bairesdev & General Partner	San Francisco Bay Area, United States	Email Phone